Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 17-Jan-2023 8:00 AM EST
Improving Adult Immunization Rates the Focus of Partnership Between ATS and Three Health Systems Across the U.S.
American Thoracic Society (ATS)

NEW YORK, NY – Jan. 17, 2023 – The American Thoracic Society is starting the new year poised to improve vaccination rates with three health system partners: University of Arizona/ Banner Health; West Virginia University Hospitals, Inc.; and San Francisco Health Network/ University of California.

Newswise: 20,000 premature US deaths caused by human-ignited fires
Released: 16-Jan-2023 4:55 PM EST
20,000 premature US deaths caused by human-ignited fires
Institute of Physics (IOP) Publishing

Over 80% of premature deaths caused by small smoke particles in the United States result directly from human-ignited fires.

   
Released: 16-Jan-2023 3:45 PM EST
Gone fishing: highly accurate test for common respiratory viruses uses DNA as ‘bait’
University of Cambridge

A new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, and gives highly accurate results in under an hour, has been developed by Cambridge researchers.

Released: 13-Jan-2023 1:20 PM EST
AI improves detail, estimate of urban air pollution
Cornell University

Using artificial intelligence, Cornell University engineers have simplified and reinforced models that accurately calculate the fine particulate matter (PM2.5) – the soot, dust and exhaust emitted by trucks and cars that get into human lungs – contained in urban air pollution.

   
Newswise: Half a million lives could be saved yearly by replacing wood and charcoal stoves in Africa
Released: 12-Jan-2023 4:25 PM EST
Half a million lives could be saved yearly by replacing wood and charcoal stoves in Africa
Kungliga Tekniska Högskolan (KTH) [Royal Institute of Technology]

Half a million lives could be saved each year in sub-Saharan Africa by taking action to reduce reliance on traditional wood- and charcoal-burning stoves, a new study shows.

   
Newswise: Save the Date! Washington, DC to Host ATS 2023
Released: 11-Jan-2023 11:05 AM EST
Save the Date! Washington, DC to Host ATS 2023
American Thoracic Society (ATS)

It has been six years since the ATS International Conference was last held in Washington, DC, and the world has changed dramatically. We are excited to welcome you back to the nation’s capital for ATS 2023, when we will engage leaders, as well as emerging scientists and clinicians, in passionate discussions of medical breakthroughs and clinical innovation to meet the needs of patients worldwide.

Newswise: Elite divers could give insights into lung disease
Released: 10-Jan-2023 2:35 PM EST
Elite divers could give insights into lung disease
University of Oregon

Scientists detected deep divers make adaptations that make their hearts and lungs work more effectively in low oxygen conditions.

   
Newswise: ACI Workshop to Examine New Test Methods for Cleaning Product Safety
Released: 10-Jan-2023 12:35 PM EST
ACI Workshop to Examine New Test Methods for Cleaning Product Safety
American Cleaning Institute

What are the best available non-animal scientific methods to assess the potential hazard of respiratory irritation throughout the life cycle of cleaning products? The American Cleaning Institute is hosting a workshop March 2, 2023 in Arlington, Virginia that will bring together leading experts who will explore “New Approach Methods (NAMs) for the In Vitro Assessment of Cleaning Products for Respiratory Irritation.”

   
Newswise: Cedars-Sinai Streamlines Lung Cancer Screening
Released: 10-Jan-2023 11:05 AM EST
Cedars-Sinai Streamlines Lung Cancer Screening
Cedars-Sinai

Cedars-Sinai Cancer is taking on the country’s leading cause of cancer-related death with a new Lung Cancer Screening Program designed to reach more patients, simplify the screening process, and provide fast access to follow-up care.

Released: 9-Jan-2023 5:35 PM EST
B.C. sea sponge has COVID-blocking powers
University of British Columbia

UBC researchers have identified three compounds that prevent COVID-19 infection in human cells, derived from natural sources including a B.C. sea sponge.

Released: 6-Jan-2023 6:05 PM EST
Tip Sheet: New genetic risk factors identified for colorectal cancer, new challenge trial on a tuberculosis vaccine — and 2022 news highlights
Fred Hutchinson Cancer Center

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. Interested in news you may have missed in 2022 from Fred Hutch?

Released: 6-Jan-2023 5:45 PM EST
More than two billion are infected with this disease; Vitamin D can help
University of Copenhagen, Faculty of Health and Medical Sciences

Sarcomas are cancer tumours found in e.g. the bones, muscles or fatty tissue. It is a rare type of cancer seen in only one per cent of cancer patients. It is complex and difficult to treat.

Newswise: Study links specific outdoor air pollutants to asthma attacks in urban children
Released: 5-Jan-2023 4:00 PM EST
Study links specific outdoor air pollutants to asthma attacks in urban children
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

Moderate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral asthma attacks in children and adolescents who live in low-income urban areas, a study funded by the National Institutes of Health has found.

Newswise: Machine Learning Tackles Long COVID
Released: 5-Jan-2023 11:05 AM EST
Machine Learning Tackles Long COVID
Lawrence Berkeley National Laboratory

There are so many unknowns about long COVID. Why is the range of symptoms so vast? How do pre-existing conditions play a role? Scientists have developed a machine learning tool to accelerate discoveries using actual patient data.

   
Released: 5-Jan-2023 10:15 AM EST
New Method of Donor-Lung Distribution Expected to Decrease Deaths Among Those on Transplant Waiting List
Cleveland Clinic

A new method of donor-lung distribution is projected to decrease the number of candidate deaths who are on the waitlist for lung transplant, according to a study by Cleveland Clinic and the U.S. Scientific Registry of Transplant Recipients (SRTR) published in The American Journal of Transplantation.

Newswise: UNC Researchers Tackle the E-cigarette or Vaping Product Use–associated Lung Injury (EVALI) Epidemic
Released: 4-Jan-2023 10:05 AM EST
UNC Researchers Tackle the E-cigarette or Vaping Product Use–associated Lung Injury (EVALI) Epidemic
University of North Carolina Health Care System

Although doctors and researchers sympathize with smokers wanting to quit smoking, scientists are discovering that vaping might not be a healthier alternative to smoking, especially in adolescents. E-cigarette products have recently been linked to a new, serious lung condition known as E-cigarette or Vaping Product Use-associated Lung Injury, or EVALI, which primarily affects youth and young adults. In 2019, the illness was declared an epidemic by the CDC.

Newswise: Actinidia arguta (sarunashi) juice inhibits lung cancer in mice
Released: 28-Dec-2022 8:15 PM EST
Actinidia arguta (sarunashi) juice inhibits lung cancer in mice
Okayama University

Lung cancer is the leading cause of death in Japan and across the globe. Among all the cancers, lung cancer has one of the lowest five-year survival rates.

Newswise: UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine
Released: 28-Dec-2022 11:30 AM EST
UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine
UT Southwestern Medical Center

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against infection.

Released: 28-Dec-2022 10:05 AM EST
Você está “aqui”: um guia para parar de fumar
Mayo Clinic

Se você é fumante, você pode estar no ponto em que quer parar de fumar, mas precisa de um guia para mostrar a você como ir de uma vida de tabagismo, “aqui”, para uma vida sem tabagismo, “lá”. Aqui você encontra dicas para começar a sua jornada livre do tabagismo do Dr. Patrick Bigaouette, psiquiatra do Sistema de Saúde da Mayo Clinic, em Mankato, Minnesota, EUA.

Released: 28-Dec-2022 10:05 AM EST
Usted está "aquí": guía para dejar de fumar
Mayo Clinic

Si usted fuma, es posible que esté en un punto en el que quiere dejar de hacerlo, pero necesita una guía sobre cómo llegar del "aquí" de fumar al "allí" de no fumar. Aquí hay sugerencias sobre cómo comenzar el camino libre de tabaco del Dr. Patrick Bigaouette, psiquiatra del Sistema de Salud de Mayo Clinic en Mankato, Minnesota.

Released: 28-Dec-2022 1:05 AM EST
أنت "هنا": دليل المدخن للإقلاع عن التدخين
Mayo Clinic

إذا كنت مدخنًا ، فربما تكون قد وصلت إلى النقطة التي تريد التوقف عندها ، لكنك بحاجة إلى دليل ينقلك من "هنا" ، أي أنني أدخن إلى "هناك" ، أي تركت. فيما يلي نصائح حول كيفية البدء في رحلتك للإقلاع عن التدخين من MD ، MD ، Patrick Pejauette ، MD ، من Mayo Clinic Health System في مانكاتو ، مينيسوتا..

Released: 28-Dec-2022 1:05 AM EST
您在这里:抽烟者的戒烟指南
Mayo Clinic

如果您是一名抽烟者,您可能正处于想要戒烟的阶段,但需要一份指南,指引您如何从抽烟的“这里”到达不抽烟的“那里”。以下是明尼苏达州曼凯托妙佑区域医疗系统的精神病学家Patrick Bigaouette医学博士关于如何开始您的无烟之旅的建议。

Released: 27-Dec-2022 11:05 AM EST
Free Online Course Focuses on Pediatric RSV Care
American Association of Critical-Care Nurses (AACN)

To provide vital resources during current RSV surge, AACN and Children's Hospital Association offer new eLearning course on pediatric respiratory care, available to all nurses and other clinicians at no charge.

Newswise: New Bacterial Therapy Approach to Treat Lung Cancer
Released: 23-Dec-2022 2:05 PM EST
New Bacterial Therapy Approach to Treat Lung Cancer
Columbia University School of Engineering and Applied Science

Columbia Engineering researchers report that they have developed a new experimental pipeline to combine bacterial therapy with current cancer drugs. Their study, which explores resistance to bacterial therapy at the molecular level, has achieved better treatment efficacy without additional toxicity in laboratory models.

Newswise: Cystic fibrosis drug could help treat pneumonia
Released: 22-Dec-2022 4:45 PM EST
Cystic fibrosis drug could help treat pneumonia
Charité - Universitätsmedizin Berlin

Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome.

Newswise: Flu season came early, hit hard in Tennessee
Released: 21-Dec-2022 10:45 AM EST
Flu season came early, hit hard in Tennessee
Vanderbilt University Medical Center

  Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.

Newswise: Robotic bronchoscopy shows promise to improve lung biopsies, UT Southwestern analysis shows
Released: 20-Dec-2022 2:05 PM EST
Robotic bronchoscopy shows promise to improve lung biopsies, UT Southwestern analysis shows
UT Southwestern Medical Center

Lung nodule biopsies performed with new robotic bronchoscopy technology may be safer and more effective than those done by traditional methods, a study by researchers at UT Southwestern suggests.

Released: 20-Dec-2022 8:00 AM EST
Two Yardsticks Published in Annals of Allergy, Asthma and Immunology – Third on the Way
American College of Allergy, Asthma and Immunology (ACAAI)

Two new yardsticks, Clinical Guidance for the Use of Dupilumab in Eosinophilic Esophagitis: and A Yardstick and Yardstick for Managing Cough. Part 1: in Adults and Adolescent Patients >14 years of age have been published in Annals of Allergy, Asthma and Immunology, ACAAI’s scientific journal.

Released: 19-Dec-2022 4:25 PM EST
A New Way to Make Asthma Drugs Last Longer
Thomas Jefferson University

New research into making asthma and COPD medication more potent could also improve how long they work in patients who need frequent doses

Released: 16-Dec-2022 4:20 PM EST
FDA Approves “Glowing Tumor” Imaging Drug to Aid Lung Cancer Surgery
Perelman School of Medicine at the University of Pennsylvania

The U.S. Food and Drug Administration has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and glows when stimulated by near-infrared light, making it easier for surgeons to remove tumors completely while sparing healthy tissue. Thoracic surgeons at the Center for Precision Surgery in the Abramson Cancer Center at Penn Medicine led the clinical trials evaluating the imaging agent in lung cancer, in a partnership with On Target Laboratories.

Newswise: Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center Network
Released: 16-Dec-2022 12:10 PM EST
Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center Network
Cedars-Sinai

The Pulmonary Fibrosis Foundation has named Cedars-Sinai part of its Care Center Network, a group of medical centers that have demonstrated expertise in treating and supporting people with this deadly disease.

Released: 16-Dec-2022 9:25 AM EST
New DNA Analysis Provides First Accurate Tuberculosis Genome
Rutgers University-New Brunswick

Rutgers researchers hope their genome-assembly tool will spur the development of new treatments for bacterial infections.

Released: 14-Dec-2022 1:10 PM EST
Nearly half of deaths for 12 cancers in California due to tobacco, higher than previously reported
UC Davis Health

A new study looks at cancer deaths in California due to tobacco, sounding the alarm regarding the tragic loss of life caused by tobacco addiction

Newswise: Hackensack Meridian JFK University Medical Center Now Offers The Most Advanced Robotic Bronchoscopy Technology in Central New Jersey
Released: 14-Dec-2022 12:50 PM EST
Hackensack Meridian JFK University Medical Center Now Offers The Most Advanced Robotic Bronchoscopy Technology in Central New Jersey
Hackensack Meridian Health

“Our new Ion Bronchoscopy system is a robotic-assisted minimally invasive biopsy platform. It features an ultra-thin, ultra-maneuverable catheter that allows navigation far into the lung, reaching smaller airways, said Faiz Y. Bhora, MD, FACS, chair of surgery, and chief of thoracic surgery, central region, Hackensack Meridian Health. “This platform’s unprecedented stability enables the precision needed for biopsy compared to manual techniques and the ability to diagnose lung cancer at the earliest stage when it is most treatable."

Released: 14-Dec-2022 11:45 AM EST
American Lung Association to Study New Treatment Approach for Lung Cancer
University of Chicago Medical Center

Sean P. Pitroda, MD, Assistant Professor of Radiation and Cellular Oncology at the University of Chicago, has received a Lung Cancer Discovery Award and been selected to join the American Lung Association Research Team for his work to improve treatment response in patients with metastatic non-small-cell lung cancer (mNSCLC).

Released: 9-Dec-2022 3:10 PM EST
LJI researchers find missing piece of the asthma puzzle
La Jolla Institute for Immunology

"This is a very striking and significant result that essentially separates LIGHT from any of the other inflammatory cytokines that have been implicated in the process in severe asthmatics."

   
Released: 8-Dec-2022 6:50 PM EST
Developmental Lung Cell Atlas uncovers 144 cell states
Wellcome Trust Sanger Institute

The developing human lung has been mapped in unprecedented detail, identifying 144 cell states in the early stages of life, and uncovering new links between developmental cells and lung cancer.

Newswise:Video Embedded e-cigarette-use-during-pregnancy-creates-lung-dysfunction-in-babies
VIDEO
Released: 8-Dec-2022 7:45 AM EST
E-cigarette Use during Pregnancy Creates Lung Dysfunction in Babies
American Physiological Society (APS)

Babies born to mothers who vape during pregnancy are at greater risk of developing pulmonary dysfunction, according to a new mouse study from The Ohio State University.

   
Released: 7-Dec-2022 9:05 PM EST
Some surprisingly good news about Chronic Obstructive Pulmonary Disease (COPD)
University of Toronto

Chronic Obstructive Pulmonary Disease (COPD) — a debilitating chronic lung disease that includes emphysema and chronic bronchitis — has previously been linked to mental health problems, such as depression, anxiety, and substance use disorders.

Newswise: Machine Learning Diagnoses Pneumonia by Listening to Coughs #ASA183
28-Nov-2022 1:15 PM EST
Machine Learning Diagnoses Pneumonia by Listening to Coughs #ASA183
Acoustical Society of America (ASA)

Researchers have developed a machine learning algorithm to identify cough sounds and determine whether the subject is suffering from pneumonia. Because every room and recording device is different, they augmented their recordings with room impulse responses, which measure how the acoustics of a space react to different sound frequencies. By combining this data with the recorded cough sounds, the algorithm can work in any environment.

   
Newswise: Household Air Cleaners Improve Heart Health Among Individuals with COPD, Researchers Find
Released: 5-Dec-2022 10:00 AM EST
Household Air Cleaners Improve Heart Health Among Individuals with COPD, Researchers Find
Johns Hopkins Medicine

A six-month study led by Johns Hopkins Medicine researchers concludes that the use of portable home air purifiers can improve some markers of cardiovascular health in people with chronic obstructive pulmonary disease, or COPD

Not for public release

This news release is embargoed until 2-Dec-2022 12:15 AM EST Released to reporters: 29-Nov-2022 4:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Dec-2022 12:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
Released: 1-Dec-2022 2:30 PM EST
Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
University of North Carolina School of Medicine

SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.

Newswise: Lung Cancer Screening Has the Potential to Reduce HIV Deaths
Released: 1-Dec-2022 8:00 AM EST
Lung Cancer Screening Has the Potential to Reduce HIV Deaths
American Thoracic Society (ATS)

This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on the health care community to increase lung cancer screening for people with HIV who are current or former heavy smokers and may be at high risk for developing the disease. As HIV- infected individuals have high smoking rates, smoking cessation should also be encouraged.

Newswise: Excess Oxygen During Anesthesia Linked to Risk of Organ Injury

 
28-Nov-2022 5:10 PM EST
Excess Oxygen During Anesthesia Linked to Risk of Organ Injury  
Vanderbilt University Medical Center

Unnecessarily high concentrations of oxygen given to patients under general anesthesia may increase risk of injury to the kidneys, lungs and heart, according to a large Vanderbilt University Medical Center-led study published in The BMJ, the flagship journal of the British Medical Association.

Released: 30-Nov-2022 1:05 PM EST
Undernutrition prior to and at treatment initiation for tuberculosis associated with unfavorable outcomes
Boston University School of Medicine

In 2021, an estimated 10.6 million individuals developed tuberculosis (TB) and 1.6 million died, making it the second most lethal infection in the world after SARS-CoV-2.

Released: 30-Nov-2022 12:00 PM EST
MD Anderson Research Highlights for November 30, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

   


close
2.10872